Frank Bedu - Dec 2, 2022 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Role
President/CEO, Director
Signature
/s/ Frank Bedu-Addo
Stock symbol
PDSB
Transactions as of
Dec 2, 2022
Transactions value $
-$270,955
Form type
4
Date filed
12/2/2022, 03:47 PM
Previous filing
Jan 20, 2022
Next filing
Jan 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PDSB Common Stock Options Exercise $1.44M +220K +33.96% $6.57 866K Dec 2, 2022 Direct F2
transaction PDSB Common Stock Tax liability -$1.71M -175K -20.23% $9.78 691K Dec 2, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PDSB Stock Option (Right to Buy) Options Exercise $0 -220K -100% $0.00* 0 Dec 2, 2022 Common Stock 220K $6.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option was fully vested in accordance with its terms.
F2 On December 2, 2022, Dr. Bedu-Addo made a net exercise of 219,535 stock options, resulting in his acquisition of 44,351 common shares of the Issuer.